RA Capital Management, LLC, Director, 10% Owner at Ra Pharmaceuticals, Inc. (RARX), bought 1,006,452 shares at $15.50 ($15.6M) on 2018-12-12, disclosed to the SEC on 2018-12-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ARVN | BUY | 2018-10-03 | $16.0M | — | Filing → |
| WVE | BUY | 2017-11-15 | $9.9M | — | Filing → |
| KALV | BUY | 2017-10-16 | $7.2M | — | Filing → |